Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Blood pressure control and its associated factors among patients with heart failure in Jordan

Journal of Human Hypertension (2023)Cite this article

Subjects

Abstract

Uncontrolled blood pressure (BP) has been associated with increased risk of cardiovascular events including heart failure. This study aimed to explore the factors associated with poor BP control among patients with heart failure at two major outpatient cardiology clinics in Jordan. Variables including socio-demographics, biomedical variables, in addition to disease and medication characteristics were collected using medical records and custom-designed questionnaire. The validated 4-item Medication Adherence Scale was used to assess medication adherence. Binary logistic regression analysis was conducted to explore the significant and independent predictors of poor BP control. Regression analysis results revealed that being not satisfied with the prescribed medication (OR = 2.882; 95% CI: 1.458–5.695; P < 0.01), reporting moderate medication adherence (OR = 0.203; 95% CI: 22 0.048–0.863; P < 0.05), not receiving digoxin (OR = 3.423; 95% CI: 1.346–8.707; P < 0.05), and not receiving aldosterone antagonist (OR = 2.044; 95% CI: 1.038-4.025; P < 0.05) were associated with poor BP control. Future interventions should focus on increasing medication satisfaction and enhancing medication adherence, in order to improve BP control among patients with heart failure.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Data availability

The data generated and/or analyzed during the present study are available from the corresponding author on reasonable request.

References

  1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240–327.

    PubMed  Google Scholar 

  2. GBD. Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.

    Article  Google Scholar 

  3. World Health Organization. Noncommunicable diseases country profiles 2018. 2018. https://apps.who.int/iris/handle/10665/274512.

  4. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Stevens G, Mascarenhas M, Mathers C. Global health risks: progress and challenges. Bull World Health Organ. 2009;87:646.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The Progression From Hypertension to Congestive Heart Failure. JAMA. 1996;275:1557–62.

    Article  CAS  PubMed  Google Scholar 

  7. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289:2363–9.

    Article  PubMed  Google Scholar 

  8. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72.

    Article  PubMed  Google Scholar 

  9. Whelton PK, He J. Blood pressure reduction. In: Hennekens CH, Buring JE, Manson JE, Ridker PM, editors. Clinical trials in cardiovascular disease. A companion to Braunwald’s heart disease. Philadelphia: WB Saunders; 1999:341–359.

  10. Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;356:1955–64.

    Article  CAS  PubMed  Google Scholar 

  11. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69–75.

    Article  CAS  PubMed  Google Scholar 

  12. Cuspidi C, Valerio C, Negri F, Sala C, Masaidi M, Giudici V, et al. Prevalence and correlates of multiple organ damage in referred treated hypertensives: data from the ETODH study. J Hum Hypertens. 2008;22:801–3.

    Article  CAS  PubMed  Google Scholar 

  13. Whitworth JA. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983–92. 2003

    Article  PubMed  Google Scholar 

  14. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305–13.

    Article  CAS  PubMed  Google Scholar 

  15. Hill MN, Bone LR, Kim MT, Miller DJ, Dennison CR, Levine DM. Barriers to hypertension care and control in young urban black men. Am J Hypertens. 1999;12:951–8.

    Article  CAS  PubMed  Google Scholar 

  16. Prugger C, Keil U, Wellmann J, de Bacquer D, de Backer G, Ambrosio GB, et al. Blood pressure control and knowledge of target blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. J Hypertens. 2011;29:1641–8.

    Article  CAS  PubMed  Google Scholar 

  17. Ham OK, Yang SJ. Lifestyle factors associated with blood pressure control among those taking antihypertensive medication. Asia Pac J Public Health. 2011;23:485–95.

    Article  PubMed  Google Scholar 

  18. Gaggin HK, Januzzi JL. Cardiac biomarkers and heart failure. American College of Cardiology; 2015. https://www.acc.org/%2Flatest-in-cardiology%2Farticles%2F2015%2F02%2F09%2F13%2F00%2Fcardiac-biomarkers-and-heart-failure.

  19. Flack JM, Calhoun D, Schiffrin EL. The new ACC/AHA hypertension guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults. Am J Hypertens. 2017;31:133–5.

    Article  Google Scholar 

  20. Chapter 2. Measurement and clinical evaluation of blood pressure. Hypertens Res. 2009;32:11–23.

    Article  Google Scholar 

  21. Elhenawy YI, Abdelmageed RI, Zaafar DK, Abdelaziz AW. Adherence to insulin therapy among children with type 1 diabetes: reliability and validity of the Arabic version of the 4-item Morisky Medication Adherence Scale. Patient Prefer Adherence. 2022;16:1415–21.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.

    Article  CAS  PubMed  Google Scholar 

  23. Lee HSC, Lee HSC, Lee HSC, Lee HSC. Abstract P157: challenging blood pressure control in heart failure patients and related factors. Hypertension. 2020;76:AP157–AP.

    Article  Google Scholar 

  24. Okaka EI, Ojeh-Oziegbe OE, Unuigbe EI. Factors associated with blood pressure control in predialysis chronic kidney disease patients: Short-term experience from a single center in Southern Nigeria. Niger J Clin Pr. 2017;20:537–41.

    Article  CAS  Google Scholar 

  25. Mbwete GW, Kilonzo KG, Shao ER, Chamba NG. Suboptimal blood pressure control, associated factors, and choice of antihypertensive drugs among type 2 diabetic patients at KCMC, Tanzania. J Diabetes Res. 2020;2020:4376251.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Xu D, Chen W, Li X, Zhang Y, Li X, Lei H, et al. Factors associated with blood pressure control in hypertensive patients with coronary heart disease: evidence from the Chinese cholesterol education program. PLOS One. 2013;8:e63135.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lip GY, Skjøth F, Overvad K, Rasmussen LH, Larsen TB. Blood pressure and prognosis in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. Clin Res Cardiol. 2015;104:1088–96.

    Article  PubMed  Google Scholar 

  28. Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, et al. Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart. 2009;95:56–62.

    Article  CAS  PubMed  Google Scholar 

  29. Schmid FA, Schlager O, Keller P, Seifert B, Huang R, Fröhlich GM, et al. Prognostic value of long‐term blood pressure changes in patients with chronic heart failure. Eur J Heart Fail. 2017;19:837–42.

    Article  PubMed  Google Scholar 

  30. Hoffmann TC, Lewis J, Maher CG. Shared decision making should be an integral part of physiotherapy practice. Physiotherapy. 2020;107:43–9.

    Article  PubMed  Google Scholar 

  31. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.

    Article  PubMed  Google Scholar 

  32. Hamarneh D, Alkhatib N, Denhaerynck K, Vancayzeele S, Brié H, MacDonald K, et al. Gender-stratified hierarchical modeling of patient and physician determinants of antihypertensive treatment outcomes: pooled analysis of seven prospective real-world studies with 17,044 patients. Curr Med Res Opin. 2021;37:367–75.

  33. Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48:562–70.

    Article  PubMed  Google Scholar 

  34. Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P, et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax. 2012;67:751–3.

    Article  PubMed  Google Scholar 

  35. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, et al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Car Fail. 2011;17:664–9.

    Article  Google Scholar 

  36. Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, et al. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532–46.

    Article  PubMed  Google Scholar 

  37. Haley WE, Gilbert ON, Riley RF, Newman JC, Roumie CL, Whittle J, et al. The association between self- reported medication adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens. 2016;10:857–64.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Centers for Disease Control and Prevention (CDC). Vital signs: awareness and treatment of uncontrolled hypertension among adults-United States, 2003-2010. MMWR Morb Mortal Wkly Rep. 2012;61:703–9.

    Google Scholar 

  39. About digoxin. 2020. https://www.nhs.uk/medicines/digoxin/about-digoxin/.

  40. Kirch C, Grossmann M, Fischer S, Neumeister V, Kirch W. Effect of digoxin on circadian blood pressure values in patients with congestive heart failure. Eur J Clin Invest. 2000;30:285–9.

    Article  CAS  PubMed  Google Scholar 

  41. Grossmann M, Jamieson M, Kirch W. Effects of digoxin and digitoxin on circadian blood pressure profile in healthy volunteers. Eur J Clin Invest. 1998;28:701–6.

    Article  CAS  PubMed  Google Scholar 

  42. How do aldosterone antagonists work? 2022. https://my.clevelandclinic.org/health/treatments/22917-aldosterone-antagonists.

  43. List of Aldosterone receptor antagonists. 2022. https://www.drugs.com/drug-class/aldosterone-receptor-antagonists.html.

  44. Liu G, Zheng XX, Xu YL, Lu J, Hui RT, Huang XH. Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis. J Hum Hypertens. 2015;29:159–66.

    Article  CAS  PubMed  Google Scholar 

  45. Marcy TR, Ripley TL. Aldosterone antagonists in the treatment of heart failure. Am J Health Syst Pharm. 2006;63:49–58.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, P.O. Box 3030, Irbid, 22110, Jordan

    Anan S. Jarab, Hanan W. Hamam, Shrouq R. Abu Heshmeh & Tareq L. Mukattash

  2. College of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates

    Anan S. Jarab

  3. Department of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, P.O. Box 130, Amman, 11733, Jordan

    Walid A. Al-Qerem

Authors
  1. Anan S. Jarab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanan W. Hamam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Walid A. Al-Qerem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shrouq R. Abu Heshmeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tareq L. Mukattash
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by AJ, WA, and HH. The first draft of the manuscript was written by HH, SA, and AJ and all authors commented on previous versions of the manuscript. All authors read and approved the final draft of the manuscript.

Corresponding author

Correspondence to Anan S. Jarab.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

Ethical approval was obtained from the Institutional Review Board (IRB) of KAUH at Jordan University of Science and Technology (Ref. # 32/141/2021) on July 1st, 2021.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jarab, A.S., Hamam, H.W., Al-Qerem, W.A. et al. Blood pressure control and its associated factors among patients with heart failure in Jordan. J Hum Hypertens (2023). https://doi.org/10.1038/s41371-023-00807-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41371-023-00807-z

Search

Advanced search

Quick links